Group 1 - The stock price of Haobo Bio has increased by 1.08% to 184.68 CNY per share, with a trading volume of 135 million CNY and a turnover rate of 1.15%, resulting in a total market capitalization of 11.723 billion CNY [1] - Haobo Bio's stock has risen for three consecutive days, with a cumulative increase of 6.66% during this period [1] - The company, established on June 8, 2009, specializes in the research, production, and sales of in vitro diagnostic reagents, with 89.46% of its revenue coming from reagent sales [1] Group 2 - According to data, one fund under China Merchants Fund holds Haobo Bio as its ninth largest position, with a net value proportion of 4.31% [2] - The fund, China Merchants Growth Pioneer Stock A, reduced its holdings by 603 shares in the third quarter, now holding 10,700 shares [2] - The fund has achieved a year-to-date return of 30.67% and a one-year return of 23.52%, ranking 1082 out of 4206 and 1713 out of 3983 respectively [2]
浩欧博股价连续3天上涨累计涨幅6.66%,招商基金旗下1只基金持1.07万股,浮盈赚取12.31万元